Literature DB >> 7713311

Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence.

M Ohneda1, L R Inman, R H Unger.   

Abstract

Pre-diabetic male Zucker diabetic fatty rats (ZDF) become diabetic between 8 and 10 weeks of age. At that time their beta cells exhibit high basal insulin secretion, absent insulin response to glucose and loss of GLUT 2 glucose transporter. Beta-cell volume, which is increased at the onset of non-insulin-dependent diabetes, declines precipitously by age 18 weeks. To determine if expression of this diabetic phenotype was dependent upon the increased food intake of these rats, they were diet-matched to lean littermates for 12 weeks beginning at 6 weeks of age. Untreated control ZDF rats received an unrestricted diet for 3 months. All of the controls became hyperglycaemic by 8 weeks of age, whereas all diet-matched rats remained euglycaemic throughout the 3 months, despite the fact that at 18 weeks of age their mean body weight equaled that of obese rats on an unrestricted diet. In the former rats glucose-stimulated insulin secretion was absent at 12 weeks of age and GLUT-2-positive beta cells had fallen below 30%. The volume fraction of their beta cells was 2.6 times normal at this age but by 18 weeks of age it had declined by 75%. Diet restriction for 3 months prevented the loss of glucose-stimulated insulin secretion and the reduction of beta-cell GLUT-2 and beta-cell volume fraction. However, neither the elevated basal insulin secretion nor the exaggerated arginine-stimulated insulin secretion of the obese rats was reversed or prevented by caloric restriction.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713311     DOI: 10.1007/bf00400091

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  23 in total

1.  The in vitro perfused pancreas.

Authors:  G M Grodsky; R E Fanska
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

3.  Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus.

Authors:  P J Savage; L J Bennion; E V Flock; M Nagulesparan; D Mott; J Roth; R H Unger; P H Bennett
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

4.  The influence of age and dietary conditions on diabetes in the db mouse.

Authors:  B M Wyse; W E Dulin
Journal:  Diabetologia       Date:  1970-06       Impact factor: 10.122

5.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

6.  Adrenergically mediated intrapancreatic control of the glucagon response to glucopenia in the isolated rat pancreas.

Authors:  A Hisatomi; H Maruyama; L Orci; M Vasko; R H Unger
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

7.  Interference of glycogenolysis with glycolysis in pancreatic islets from glucose-infused rats.

Authors:  W J Malaisse; C Maggetto; V Leclercq-Meyer; A Sener
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

8.  Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release.

Authors:  M L Elks
Journal:  Endocrinology       Date:  1993-07       Impact factor: 4.736

9.  Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle.

Authors:  Y P Zhou; V E Grill
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

10.  Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetics.

Authors:  H Hidaka; M Nagulesparan; I Klimes; R Clark; H Sasaki; S L Aronoff; B Vasquez; A H Rubenstein; R H Unger
Journal:  J Clin Endocrinol Metab       Date:  1982-02       Impact factor: 5.958

View more
  29 in total

1.  Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1beta cytotoxicity.

Authors:  M Shimabukuro; K Koyama; Y Lee; R H Unger
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

2.  Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.

Authors:  T Shibata; S Takeuchi; S Yokota; K Kakimoto; F Yonemori; K Wakitani
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

3.  Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains.

Authors:  Huw Bowen Jones; David Nugent; Richard Jenkins
Journal:  Int J Exp Pathol       Date:  2010-04-01       Impact factor: 1.925

4.  Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats.

Authors:  M Higa; Y T Zhou; M Ravazzola; D Baetens; L Orci; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

5.  Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes.

Authors:  M Shimabukuro; Y T Zhou; M Levi; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

Review 6.  Impact of diet restriction in the management of diabetes: evidences from preclinical studies.

Authors:  Pawan Krishan; Onkar Bedi; Monika Rani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-12-16       Impact factor: 3.000

7.  Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition.

Authors:  X Yu; S McCorkle; M Wang; Y Lee; J Li; A K Saha; R H Unger; N B Ruderman
Journal:  Diabetologia       Date:  2004-12-02       Impact factor: 10.122

8.  Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice.

Authors:  Alexis M Stranahan; Kim Lee; Bronwen Martin; Stuart Maudsley; Erin Golden; Roy G Cutler; Mark P Mattson
Journal:  Hippocampus       Date:  2009-10       Impact factor: 3.899

9.  Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression.

Authors:  M Shimabukuro; M Y Wang; Y T Zhou; C B Newgard; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  GLP-1 derivative liraglutide in rats with beta-cell deficiencies: influence of metabolic state on beta-cell mass dynamics.

Authors:  Jeppe Sturis; Carsten F Gotfredsen; John Rømer; Bidda Rolin; Ulla Ribel; Christian L Brand; Michael Wilken; Karsten Wassermann; Carolyn F Deacon; Richard D Carr; Lotte Bjerre Knudsen
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.